Today: 7 February 2026
Subscribe
Browse Category

Cannabis Industry News 4 November 2025 - 12 December 2025

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. (NASDAQ: CRON , TSX: CRON ) is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III .Reuters+ 1 For Cronos investors, today’s move is not happening in a vacuum. The stock entered December with fresh momentum after the company announced a strategic acquisition in the Netherlands , a deal that management says would give Cronos the #1 market share within Europe’s largest
12 December 2025
·····
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation stock (NASDAQ: CGC ; TSX: WEED ) is in the spotlight on Friday, December 12, 2025 , after a fresh wave of US federal policy speculation sent cannabis names sharply higher in premarket trading. The immediate catalyst: a report that President Donald Trump is expected to push for a major easing of federal marijuana restrictions—specifically, directing agencies to reclassify marijuana as a Schedule III drug . That headline quickly rippled through US-listed cannabis stocks, with Canopy Growth among the notable movers.Reuters+ 1 Below is a detailed round-up of today’s key news , today’s market reaction , and
12 December 2025
······
Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (NASDAQ: TLRY) is surging as cannabis stocks rally on fresh U.S. rescheduling headlines. Here’s what’s driving TLRY, what analysts forecast, and what to watch next. Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight on Friday, December 12, 2025, after a sharp move higher in extended-hours trading and premarket action alongside a broader rally in cannabis-linked equities. The immediate catalyst is political: a report that President Donald Trump is expected to push the federal government to loosen marijuana restrictions by directing agencies toward reclassifying marijuana as a Schedule III substance—a shift that could materially change
12 December 2025
·····
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

Updated: Friday, December 12, 2025 — 6:00 a.m. ET SEO summary: Here are the biggest US stock market premarket gainers today (NYSE/Nasdaq) and the news driving them, including Lululemon’s earnings and CEO transition, a cannabis-stock surge tied to marijuana rescheduling headlines, and earnings-driven jumps in Mitek and Quanex. Nasdaq+4StockAnalysis+4Reuters+4 US stock futures were mixed early Friday, with investors balancing a post-Fed backdrop against renewed questions around big-tech AI spending after Oracle’s latest move and broader positioning into year-end. Reuters Below is a detailed look at the top premarket gainers as of about 6:00 a.m. ET, plus the headlines, forecasts, and analyst takes circulating on 12/12/2025. Top premarket stock gainers right now (as of ~6:00 a.m. ET) These are the leading percentage gainers in
12 December 2025
·············
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

As of December 10, 2025 Tilray stock rebounds 12% after brutal selling Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) just reminded investors how violently cannabis stocks can move. On Tuesday, December 9, 2025, TLRY jumped about 12.4% to close around $8.09, sharply outperforming a flat broader market. Trading volume topped 8.6 million shares, above the 50‑day average of roughly 7.8 million. Even after that rally, Tilray’s share price is still about 65% below its 52‑week high of $23.20, reached on October 9. MarketWatch+1 The surge followed weeks of heavy selling. On December 3, the stock fell 8.4% to $7.06, marking
10 December 2025
·····
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis Inc. (NASDAQ: ACB; TSX: ACB) is ending 2025 in a very different place from where it started. After years of restructuring, the company has become a highly focused global medical cannabis business, with new partnerships in Australia, expanding operations in Europe, and back‑to‑back quarters of record medical revenue. As of the latest trading sessions before December 7, 2025, ACB’s U.S.-listed shares trade around US$4.60, while the TSX listing changes hands near C$6.39, giving the company a market value in roughly the US$260–280 million range. Investing.com+2Stock Titan+2 Here’s a deep dive into the latest news, earnings, forecasts and analyses
7 December 2025
····
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

December 6, 2025 Canopy Growth Stock Snapshot as of December 6, 2025 Canopy Growth Corp (NASDAQ: CGC, TSX: WEED) remains one of the most volatile names in global cannabis — and 2025 has been no exception. In other words, CGC is bouncing off its lows but still priced like a distressed turnaround. Q2 FY2026 Earnings: Margins Improve, Losses Narrow Canopy’s second quarter of fiscal 2026 (three months ended September 30, 2025) was the first real proof that its years‑long restructuring might be gaining traction. According to the company’s official earnings release and independent summaries: Canopy Growth+1 Fintool’s recap notes that,
6 December 2025
······
Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Brands stock (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight this Sunday, November 23, 2025, for all the reasons that make cannabis names both fascinating and stressful to follow:the share price has slipped back under $1, new AI-driven trading plans dropped this morning, a fresh “millionaire maker” think-piece is circulating, and regulators are pulling the sector in opposite directions. Here’s a full breakdown of everything new on Tilray today, plus the key numbers, fundamentals, and risks traders are weighing right now. Tilray stock price snapshot for November 23, 2025 Because U.S. markets are closed today (Sunday), the latest
23 November 2025
····
Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Published: November 23, 2025 Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in focus today as new AI-driven trading signals, updated valuation models, and recent analyst forecasts collide with a volatile share price that’s again trading under $1. TLRY stock today: trading under $1 after a bruising week As of this weekend, Tilray Brands’ U.S.-listed stock is trading around $0.91 per share, with Friday’s official close at $0.91 on the Nasdaq. MarketBeat+1 Over just the past week of trading (Nov. 17–21), TLRY slid from about $1.03 to $0.91, a decline of roughly 12%, marking five straight down days and
23 November 2025
··
Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (NASDAQ: AKAN) is back in the news today after outlining the next steps toward a full Health Canada cultivation license at its British Columbia cannabis site, while commentators highlight the company’s unusual mix of Mexican telecom infrastructure and Canadian cannabis “optionality.” Newsfile+1 A fresh Newsfile press release this morning details how Akanda will design and implement Health Canada–compliant security at its Gabriola Island facility, a prerequisite for producing THC- and CBD-rich cannabis under a full cultivation license. Newsfile+1 At the same time, a new MarketScreener feature frames Akanda as a “dual‑track” small cap: cash flow from towers and
14 November 2025
·
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth Corporation (NASDAQ: CGC; TSX: WEED) reported second‑quarter fiscal 2026 results today that highlight improving operations, tighter cost control, and a stronger balance sheet. The company ended the quarter with C$298 million in cash and cash equivalents, exceeding total debt by C$70 million—and said the conditions that had previously raised “substantial doubt” about its ability to continue as a going concern have been resolved. Canopy Growth Market reaction Investors initially cheered the update: CGC rose ~19% in premarket trading after the release. Shares have since been volatile through the session. Seeking Alpha By the numbers (Q2 FY2026, quarter ended
7 November 2025
···
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. (NASDAQ: SNDL), one of Canada’s largest cannabis and liquor retailers, just released its third-quarter 2025 results, sending its stock price tumbling. Below is a summary of key facts, followed by an in-depth analysis of the latest news, financials, expert opinions, forecasts, and how SNDL compares to peers in the cannabis sector. Recent News and Developments (Late Oct – Early Nov 2025) In the days surrounding the Q3 earnings release, SNDL Inc. was in the headlines for several reasons: In summary, the recent news cycle for SNDL has been dominated by its earnings announcement and the market’s reaction. Now
4 November 2025
····
1 2 3

Stock Market Today

Eli Lilly stock rises after FDA steps up crackdown on GLP-1 copycats

Eli Lilly stock rises after FDA steps up crackdown on GLP-1 copycats

7 February 2026
Eli Lilly shares climbed 3.7% in after-hours trading after the FDA announced plans to restrict GLP-1 ingredients in unapproved compounded drugs. Hims & Hers shares dropped nearly 12% after being referred for a Justice Department probe. Investors are watching for details on enforcement and pricing pressure as the market reacts to moves against copycat obesity drugs.
IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

7 February 2026
IREN Limited shares rose 5.1% to $41.83 in after-hours trading Friday as bitcoin jumped 11.4% to $71,198, lifting crypto-linked stocks. The company reported $184.7 million in quarterly revenue, with $167.4 million from bitcoin mining and $17.3 million from AI cloud services. Net loss reached $155.4 million. IREN recently announced $3.6 billion in GPU financing for a Microsoft contract and a new Oklahoma data center.
Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

7 February 2026
The U.S. Justice Department is investigating Netflix’s business practices as part of its review of the proposed Warner Bros Discovery deal, the Wall Street Journal reported Friday. Netflix shares rose 1.6% to $82.20 in after-hours trading. Warner expects a shareholder vote on the deal in March. Paramount Skydance’s rival bid remains active.
Go toTop